Randomised Cross-Over Study to Evaluate the Isolated Effect of Formoterol and Combined With Tiotropium on Breathlessness, Dynamic Hyperinflation and Exercise Tolerance in Moderate-to-Severe Stable COPD Patients

Trial Profile

Randomised Cross-Over Study to Evaluate the Isolated Effect of Formoterol and Combined With Tiotropium on Breathlessness, Dynamic Hyperinflation and Exercise Tolerance in Moderate-to-Severe Stable COPD Patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Sep 2010

At a glance

  • Drugs Tiotropium bromide (Primary) ; Formoterol
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 04 Dec 2009 Actual patient number (33) added as reported by ClinicalTrials.gov.
    • 04 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top